-
公开(公告)号：AT237610T
公开(公告)日：2003-05-15
申请号：AT00610050
申请日：2000-05-22
Applicant: SERVIER LAB
Inventor： DEPREUX PATRICK , YOUS SAID , CHEVE GWENAEL , GUILLAUMET GERALD , VIAUD MARIE-CLAUDE , LARRAYA CARLOS , BENNEJEAN CAROLINE , DELAGRANGE PHILIPPE , REGARD PIERRE , DESCAMPS-FRANCOIS CAROLE
IPC: C07D319/20 , A61K31/24 , A61K31/34 , A61K31/343 , A61K31/352 , A61K31/357 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/403 , A61K31/404 , A61K31/4355 , A61K31/44 , A61P1/14 , A61P3/00 , A61P9/00 , A61P9/02 , A61P25/00 , A61P25/20 , A61P25/24 , A61P25/28 , A61P43/00 , C07C233/22 , C07D209/16 , C07D307/79 , C07D307/80 , C07D307/81 , C07D311/58 , C07D333/58 , C07D333/60 , C07D333/66 , C07D339/08 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/12 , C07D409/12 , C07D471/04
Abstract: The invention relates to compound of formula (I):wherein:A represents a grouping NR1C(Q)R2, C(Q)NR2R3 or NR1C(Q)NR2R3,B represents a grouping NR1C(Q)R2, NR1C(Q)NR2R3, C(Q)NR2R3, C(Q)OR1, NR1C(Q)OR2 or NR2R3,G1 and G3 represent an optionally substituted alkylene chain,Cy and Cy', which are different, represent a ring structureorG2 represents a chainand medicinal products containing the same are useful in treating or in preventing melatoninergic disorders.
-
Patent Agency Ranking
公开(公告)号：DE60002126T2
公开(公告)日：2004-03-18
申请号：DE60002126
申请日：2000-05-22
Applicant: SERVIER LAB
Inventor： DEPREUX PATRICK , YOUS SAID , CHEVE GWENAEL , GUILLAUMET GERALD , VIAUD MARIE-CLAUDE , LARRAYA CARLOS , BENNEJEAN CAROLINE , DELAGRANGE PHILIPPE , REGARD PIERRE , DESCAMPS-FRANCOIS CAROLE
IPC: C07D319/20 , A61K31/24 , A61K31/34 , A61K31/343 , A61K31/352 , A61K31/357 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/403 , A61K31/404 , A61K31/4355 , A61K31/44 , A61P1/14 , A61P3/00 , A61P9/00 , A61P9/02 , A61P25/00 , A61P25/20 , A61P25/24 , A61P25/28 , A61P43/00 , C07C233/22 , C07D209/16 , C07D307/79 , C07D307/80 , C07D307/81 , C07D311/58 , C07D333/58 , C07D333/60 , C07D333/66 , C07D339/08 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/12 , C07D409/12 , C07D471/04
Abstract: The invention relates to compound of formula (I):wherein:A represents a grouping NR1C(Q)R2, C(Q)NR2R3 or NR1C(Q)NR2R3,B represents a grouping NR1C(Q)R2, NR1C(Q)NR2R3, C(Q)NR2R3, C(Q)OR1, NR1C(Q)OR2 or NR2R3,G1 and G3 represent an optionally substituted alkylene chain,Cy and Cy', which are different, represent a ring structureorG2 represents a chainand medicinal products containing the same are useful in treating or in preventing melatoninergic disorders.
-
公开(公告)号：DK1057826T3
公开(公告)日：2003-07-21
申请号：DK00610050
申请日：2000-05-22
Applicant: SERVIER LAB
Inventor： DEPREUX PATRICK , YOUS SAID , CHEVE GWENAEL , GUILLAUMET GERALD , VIAUD MARIE-CLAUDE , LARRAYA CARLOS , BENNEJEAN CAROLINE , DELAGRANGE PHILIPPE , REGARD PIERRE , DESCAMPS-FRANCOIS CAROLE
IPC: C07D319/20 , A61K31/24 , A61K31/34 , A61K31/343 , A61K31/352 , A61K31/357 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/403 , A61K31/404 , A61K31/4355 , A61K31/44 , A61P1/14 , A61P3/00 , A61P9/00 , A61P9/02 , A61P25/00 , A61P25/20 , A61P25/24 , A61P25/28 , A61P43/00 , C07C233/22 , C07D209/16 , C07D307/79 , C07D307/80 , C07D307/81 , C07D311/58 , C07D333/58 , C07D333/60 , C07D333/66 , C07D339/08 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/12 , C07D409/12 , C07D471/04
Abstract: The invention relates to compound of formula (I):wherein:A represents a grouping NR1C(Q)R2, C(Q)NR2R3 or NR1C(Q)NR2R3,B represents a grouping NR1C(Q)R2, NR1C(Q)NR2R3, C(Q)NR2R3, C(Q)OR1, NR1C(Q)OR2 or NR2R3,G1 and G3 represent an optionally substituted alkylene chain,Cy and Cy', which are different, represent a ring structureorG2 represents a chainand medicinal products containing the same are useful in treating or in preventing melatoninergic disorders.
-
公开(公告)号：PT1057826E
公开(公告)日：2003-08-29
申请号：PT00610050
申请日：2000-05-22
Applicant: SERVIER LAB
Inventor： GUILLAUMET GERALD , DEPREUX PATRICK , DELAGRANGE PHILIPPE , VIAUD MARIE-CLAUDE , BENNEJEAN CAROLINE , YOUS SAID , CHEVE GWENAEL , LARRAYA CARLOS , REGARD PIERRE , DESCAMPS-FRANCOIS CAROLE
IPC: C07D319/20 , A61K31/24 , A61K31/34 , A61K31/343 , A61K31/352 , A61K31/357 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/403 , A61K31/404 , A61K31/4355 , A61K31/44 , A61P1/14 , A61P3/00 , A61P9/00 , A61P9/02 , A61P25/00 , A61P25/20 , A61P25/24 , A61P25/28 , A61P43/00 , C07C233/22 , C07D209/16 , C07D307/79 , C07D307/80 , C07D307/81 , C07D311/58 , C07D333/58 , C07D333/60 , C07D333/66 , C07D339/08 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/12 , C07D409/12 , C07D471/04
Abstract: The invention relates to compound of formula (I):wherein:A represents a grouping NR1C(Q)R2, C(Q)NR2R3 or NR1C(Q)NR2R3,B represents a grouping NR1C(Q)R2, NR1C(Q)NR2R3, C(Q)NR2R3, C(Q)OR1, NR1C(Q)OR2 or NR2R3,G1 and G3 represent an optionally substituted alkylene chain,Cy and Cy', which are different, represent a ring structureorG2 represents a chainand medicinal products containing the same are useful in treating or in preventing melatoninergic disorders.
-
公开(公告)号：DE60002126D1
公开(公告)日：2003-05-22
申请号：DE60002126
申请日：2000-05-22
Applicant: SERVIER LAB
Inventor： DEPREUX PATRICK , YOUS SAID , CHEVE GWENAEL , GUILLAUMET GERALD , VIAUD MARIE-CLAUDE , LARRAYA CARLOS , BENNEJEAN CAROLINE , DELAGRANGE PHILIPPE , REGARD PIERRE , DESCAMPS-FRANCOIS CAROLE
IPC: C07D319/20 , A61K31/24 , A61K31/34 , A61K31/343 , A61K31/352 , A61K31/357 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/403 , A61K31/404 , A61K31/4355 , A61K31/44 , A61P1/14 , A61P3/00 , A61P9/00 , A61P9/02 , A61P25/00 , A61P25/20 , A61P25/24 , A61P25/28 , A61P43/00 , C07C233/22 , C07D209/16 , C07D307/79 , C07D307/80 , C07D307/81 , C07D311/58 , C07D333/58 , C07D333/60 , C07D333/66 , C07D339/08 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/12 , C07D409/12 , C07D471/04
Abstract: The invention relates to compound of formula (I):wherein:A represents a grouping NR1C(Q)R2, C(Q)NR2R3 or NR1C(Q)NR2R3,B represents a grouping NR1C(Q)R2, NR1C(Q)NR2R3, C(Q)NR2R3, C(Q)OR1, NR1C(Q)OR2 or NR2R3,G1 and G3 represent an optionally substituted alkylene chain,Cy and Cy', which are different, represent a ring structureorG2 represents a chainand medicinal products containing the same are useful in treating or in preventing melatoninergic disorders.
-
公开(公告)号：SI1057826T1
公开(公告)日：2003-08-31
申请号：SI200030081
申请日：2000-05-22
Applicant: SERVIER LAB
Inventor： DEPREUX PATRICK , YOUS SAID , CHEVE GWENAEL , GUILLAUMET GERALD , VIAUD MARIE-CLAUDE , LARRAYA CARLOS , BENNEJEAN CAROLINE , DELAGRANGE PHILIPPE , REGARD PIERRE , DESCAMPS-FRANCOIS CAROLE
IPC: C07D319/20 , A61K31/24 , A61K31/34 , A61K31/343 , A61K31/352 , A61K31/357 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/403 , A61K31/404 , A61K31/4355 , A61K31/44 , A61P1/14 , A61P3/00 , A61P9/00 , A61P9/02 , A61P25/00 , A61P25/20 , A61P25/24 , A61P25/28 , A61P43/00 , C07C233/22 , C07D209/16 , C07D307/79 , C07D307/80 , C07D307/81 , C07D311/58 , C07D333/58 , C07D333/60 , C07D333/66 , C07D339/08 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/12 , C07D409/12 , C07D471/04
Abstract: The invention relates to compound of formula (I):wherein:A represents a grouping NR1C(Q)R2, C(Q)NR2R3 or NR1C(Q)NR2R3,B represents a grouping NR1C(Q)R2, NR1C(Q)NR2R3, C(Q)NR2R3, C(Q)OR1, NR1C(Q)OR2 or NR2R3,G1 and G3 represent an optionally substituted alkylene chain,Cy and Cy', which are different, represent a ring structureorG2 represents a chainand medicinal products containing the same are useful in treating or in preventing melatoninergic disorders.
-
-
-
-
-
Search Results
6
records
(took 0.017 seconds)
